Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | MAOB | P27338 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19345010 | 0.85 | ALDH1A1 (0.35) | ALDH1A1KDM4EGLAGAASMN1; SMN2 | |
| SCHEMBL19340289 | 0.85 | ALDH1A1 (0.33) | ALDH1A1KDM4ESMN1; SMN2LMNAHPGD | |
| SCHEMBL19345084 | 0.83 | TSHR (0.36) | TSHRMAOAMAOB | |
| SCHEMBL19344972 | 0.82 | ALDH1A1 (0.35) | ALDH1A1KDM4EGLAGAASMN1; SMN2 | |
| SCHEMBL19340268 | 0.79 | TSHR (0.33) | ALDH1A1KDM4EGLAGAATSHR | |
| SCHEMBL19344945 | 0.78 | TSHR (0.42) | ALDH1A1TSHRMAOAMAOB | |
| SCHEMBL19345046 | 0.76 | IMPDH2 (0.34) | ALDH1A1KDM4EGLAGAALMNA | |
| SCHEMBL19344981 | 0.76 | KDM4E (0.36) | ALDH1A1KDM4EGLAGAAIMPDH2 | |
| SCHEMBL19368321 | 0.75 | ALDH1A1 (0.39) | ALDH1A1GAAHPGDMAOA | |
| SCHEMBL30253548 | 0.75 | ALDH1A1 (0.39) | ALDH1A1GAAHPGDMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170263871-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE | TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2017-09-14 | — | — | US | disclosed |
| US-20170263871-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE | TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2017-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170263871-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE | OR10J3, RPS10, OR51E2 | ALDH1A1 616/4885KDM4E 3155/4885GLA 2917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.